On Feb 1, 2022 IntelGenX closed a Post-IPO Debt round and raised $3,000,000 from ATAI Life Sciences, featuring lead investors ATAI Life Sciences.
About the company: IntelGenX is located at Canada, North America.
“Oral Film Development & Manufacturing Leader. We make approved drugs better, with next generation pharmaceutical film products. ”
Company website: http://www.intelgenx.com